Shopping Cart
- Remove All
- Your shopping cart is currently empty
Riluzole (RP-54274) is a glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
50 mg | 42 € | In Stock | |
100 mg | 55 € | In Stock | |
500 mg | 111 € | In Stock | |
1 g | 149 € | In Stock | |
1 mL x 10 mM (in DMSO) | 47 € | In Stock |
Description | Riluzole (RP-54274) is a glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS. |
Targets&IC50 | GABA:43 μM |
In vitro | Riluzole readily crosses the blood-brain barrier. Treatment of rodents with transient cerebral ischemia with 8 mg/kg i.p. Riluzole completely inhibited the massive release of glutamic acid induced by local ischemia. |
In vivo | Riluzole readily crosses the blood-brain barrier. Treatment of rodents with transient cerebral ischemia with 8 mg/kg i.p. Riluzole completely inhibited the massive release of glutamic acid induced by local ischemia. |
Alias | RP-54274, PK 26124 |
Molecular Weight | 234.2 |
Formula | C8H5F3N2OS |
Cas No. | 1744-22-5 |
Smiles | NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2 |
Relative Density. | 1.572 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 60 mg/mL (256.19 mM) H2O: < 1 mg/mL (insoluble or slightly soluble) Ethanol: 43 mg/mL (183.6 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.